2610
Administration of intrathecal Ara-C in the same dose over longer intervals within 3-5 days between consecutive doses resulted in mild, transient neurological symptoms (paresthesias) in only one of 30 patients so treated.
 ( adverse event: resulted ,  one of 30 patients: Subject, one of 30: Subject.Population, neurological symptoms: Effect, Administration of intrathecal Ara-C in the same dose over longer intervals within 3-5 days between consecutive doses: Treatment, intrathecal: Treatment.Route, Ara-C: Treatment.Drug, longer intervals within 3-5 days between consecutive doses: Treatment.Freq) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: resulted ,  one of 30 patients: Subject, one of 30: Subject.Population, neurological symptoms: Effect, Administration of intrathecal Ara-C in the same dose over longer intervals within 3-5 days between consecutive doses: Treatment, intrathecal: Treatment.Route, Ara-C: Treatment.Drug, longer intervals within 3-5 days between consecutive doses: Treatment.Freq) 